Highline Wealth Partners’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
NRW
SAM
NS
PFO
PAM
FFA
SWA
HHGA
CA
MPWT
Highline Wealth Partners's BME Position: Q2 2026 in Review
Highline Wealth Partners held its BlackRock Health Sciences Trust (BME) position steady in Q2 2026 at 75 shares worth $3.22K. The position accounts for ﹤0.01% of the portfolio, ranked #989.
Highline Wealth Partners first reported a position in BME in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold BME as of Q2 2026.
- Highline Wealth Partners held 75 shares of BlackRock Health Sciences Trust worth $3.22K as of Q2 2026.
- Highline Wealth Partners left its BlackRock Health Sciences Trust share count unchanged in Q2 2026.
- BlackRock Health Sciences Trust made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #989 holding.
- Highline Wealth Partners first reported a position in BlackRock Health Sciences Trust in Q1 2026 and has held it in 2 quarters since.
- 17 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.
Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.